Skip to content

HALV

Active
Private limited companyfounded 2023active for 3 yearsKestelstraat 105, 9880 Aalter, BelgiumKBO/BCE: BE 0801.848.223
Summary

HALV has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €95,996 and a net result of €42,100. Equity is growing by about 78% per year across the filed financial years. Its solvency ranks better than 77% of 20,604 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
General medical practice
NACE 86210
1 site
Size
€112,220total assets 2025
Equity
€95,996
Profit
€42,100
Turnover not published (micro format)
Financial health
96 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
2025 accounts 64 days early1 of 2 deeds summarised
Why 96raises riskFounded in 2023lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 6.90, cash €106,976Equity €95,996 (85.5% of total assets)Show the evidence

Checked score

Score 2025
96 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 69% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Strong
Solvency 100=
equity 85.5% of total assets
Liquidity 97+5
short-term debt 14.5% · cash 95.3%
Profitability 79-21
return on assets 37.5%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,117 companies, NACE 86, micro)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.2%▲ +0.1 percentage points vs 07-2025highest value 09-2025: < 0.1%▼ -0.2 percentage points vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026lowest value 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €9,000 on 30-day terms is acceptable
Liquidity ample (current ratio 6.9, compared with 4.19 in 2024, above the usual 1.5; short-term debt: 14.5% and cash: 95.3% of total assets), and 14.5% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 82% on solvency, 86% on liquidity, 24% on profitability and 86% on growth.

The bankruptcy probability was computed on 24-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 6.90, cash €106,976
NBB · annual accounts
lowers risk · Equity €95,996 (85.5% of total assets)
NBB · annual accounts
raises risk · Founded in 2023
Companies of this age fail more often than older ones; how much that weighs depends on the rest of its profile.
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-05-2026, 64 days ahead of the deadline.
NBB · 3 filings
Deviation from the deadline
2025
64 days early
2024
12 days late
2023
30 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 3 accounts on average 7 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 12 August (3 of the last 3 filed years within 76 days of that day).
Companies Code · seven months
Where today falls in the filing period
25-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2023.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Annual accounts filedfinancial year 2024 · micro…
  3. Highest result from 2023 to 2025net €43,884 ▲395%

Financials · financial year 2025, micro format

Equity
€95,996▲ 75.3%
2024 · €54,755
Total assets
€112,220▲ 56.6%
2024 · €71,649
Net result
€42,100▼ 4.1%
2024 · €43,884
Working capital
€95,733▲ 77.6%
2024 · €53,900
Trend over the years

2023 to 2025, 3 financial years

The operating result has risen two years in a row; 2025 is 36% above 2024 and is the highest result in the available series.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€76,165 2025 Net result€42,100 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line202320242025
Operating result€13,011-€56,129▲ 331%€76,165▲ 35.7%
Net result€8,871below the sector's middle half-€43,884within the sector's middle half▲ 395%€42,100within the sector's middle half▼ 4.1%
Equity€10,871below the sector's middle half-€54,755within the sector's middle half▲ 404%€95,996within the sector's middle half▲ 75.3%
Total assets€40,308below the sector's middle half-€71,649below the sector's middle half▲ 77.8%€112,220below the sector's middle half▲ 56.6%
Debt€29,437-€16,894▼ 42.6%€16,225▼ 4.0%
Working capital€9,424below the sector's middle half-€53,900within the sector's middle half▲ 472%€95,733within the sector's middle half▲ 77.6%
Solvency27.0%below the sector's middle half-76.4%within the sector's middle half▲ 49.5pp85.5%above the sector's middle half▲ 9.1pp
Current ratio1.32below the sector's middle half-4.19within the sector's middle half▲ 2.876.90above the sector's middle half▲ 2.71
Return on assets (ROA)22.0%within the sector's middle half-61.2%above the sector's middle half▲ 39.2pp37.5%within the sector's middle half▼ 23.7pp
above within below the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the micro format does not require them.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €112,220
Fixed assets €263 ▼ 69.3%
Current assets €111,957 ▲ 58.1%
Equity and liabilities €112,220
Equity €95,996 ▲ 75.3%
Debt €16,225 ▼ 4.0%
Debt's share of the balance-sheet total falls from 23.6% to 14.5%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€76,757▲
2024 · €56,721
Cash flow
€42,692▼
2024 · €44,476
Debt to equity
0.17▼
2024 · 0.31
ROE
43.9%▼
2024 · 80.1%
Interest coverage
3.45▼
2024 · over 100
Debt ≤ 1 year
€16,225▼
2024 · €16,894
Income taxes
€11,819▼
2024 · €12,202
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 39,278 companies that looked in July 2024 the way this one looks now, 1.8% went bankrupt within 24 months and 95.8% are still going.

  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
1.8% went bankrupt
2.3% stopped otherwise
95.8% still going

A further 0.1% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a lower bankruptcy probability: < 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,475 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 39,278 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 38 lines
Balance sheet Code20242025
Assets
Total assets20/58€71,649€112,220▲
Fixed assets21/28€855€263▼
Tangible fixed assets22/27€855€263▼
Furniture and vehicles24€855€263▼
Current assets29/58€70,794€111,957▲
Amounts receivable within one year40/41-€1,214
Other amounts receivable41-€1,214
Cash at bank and in hand54/58€68,199€106,976▲
Deferred charges and accrued income490/1€2,595€3,767▲
Equity and liabilities
Total equity and liabilities10/49€71,649€112,220▲
Equity10/15€54,755€95,996▲
Contributions10/11€2,000€2,000=
Reserves13€50,000€90,000▲
Distributable reserves133€50,000€90,000▲
Profit (loss) carried forward14€2,755€3,996▲
Amounts payable17/49€16,894€16,225▼
Amounts payable within one year42/48€16,894€16,225▼
Trade debts44€3,719€3,206▼
Suppliers440/4€3,719€3,206▼
Taxes, remuneration and social security45€12,202€13,019▲
Taxes450/3€12,202€13,019▲
Other amounts payable47/48€973-
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€592€592=
Other operating charges640/8€310€300▼
Gross operating margin9900€57,031€77,057▲
Operating profit (loss)9901€56,129€76,165▲
Financial charges65/66B€44€22,247▲
Recurring financial charges65€44€22,247▲
Profit (loss) for the period before taxes9903€56,086€53,919▼
Income taxes67/77€12,202€11,819▼
Profit (loss) for the period9904€43,884€42,100▼
Profit (loss) for the period to be appropriated9905€43,884€42,100▼
Appropriation of the result
Profit (loss) to be appropriated9906€43,884€44,855▲
Profit (loss) brought forward from the previous period14P-€2,755
Transfer to equity691/2€41,129€40,000▼
To other reserves6921€41,129€40,000▼
Profit to be distributed694/7-€859
Return on contributions (dividend)694-€859

The notes to these accounts (4 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line202320242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€329€592€592=
Other operating charges640/8€50€310€300▼ 3.4%
Gross operating margin9900€13,390€57,031€77,057▲ 35.1%
Operating profit (loss)9901€13,011€56,129€76,165▲ 35.7%
Financial charges65/66B€20€44€22,247▲ 511×
Recurring financial charges65€20€44€22,247▲ 511×
Profit (loss) for the period before taxes9903€12,991€56,086€53,919▼ 3.9%
Income taxes67/77€4,120€12,202€11,819▼ 3.1%
Profit (loss) for the period9904€8,871€43,884€42,100▼ 4.1%
Profit (loss) for the period to be appropriated9905€8,871€43,884€42,100▼ 4.1%
Line202320242025Change
Assets
Total assets20/58€40,308€71,649€112,220▲ 56.6%
Fixed assets21/28€1,447€855€263▼ 69.3%
Tangible fixed assets22/27€1,447€855€263▼ 69.3%
Furniture and vehicles24€1,447€855€263▼ 69.3%
Current assets29/58€38,862€70,794€111,957▲ 58.1%
Amounts receivable within one year40/41--€1,214-
Other amounts receivable41--€1,214-
Cash at bank and in hand54/58€37,133€68,199€106,976▲ 56.9%
Deferred charges and accrued income490/1€1,729€2,595€3,767▲ 45.1%
Equity and liabilities
Total equity and liabilities10/49€40,308€71,649€112,220▲ 56.6%
Equity10/15€10,871€54,755€95,996▲ 75.3%
Contributions10/11€2,000€2,000€2,000=
Reserves13€8,871€50,000€90,000▲ 80.0%
Distributable reserves133€8,871€50,000€90,000▲ 80.0%
Profit (loss) carried forward14-€2,755€3,996▲ 45.0%
Amounts payable17/49€29,437€16,894€16,225▼ 4.0%
Amounts payable within one year42/48€29,437€16,894€16,225▼ 4.0%
Trade debts44€18,830€3,719€3,206▼ 13.8%
Suppliers440/4€18,830€3,719€3,206▼ 13.8%
Taxes, remuneration and social security45€4,120€12,202€13,019▲ 6.7%
Taxes450/3€4,120€12,202€13,019▲ 6.7%
Other amounts payable47/48€6,487€973--
Line202320242025Change
Profit (loss) for the period9904€8,871€43,884€42,100▼ 4.1%
+ Depreciation and write-downs630€329€592€592=
Operating cash flow (approximation)€9,200€44,476€42,692▼ 4.0%
Investment in fixed assets (approximation)-€0€0-
Change in cash-€31,066€38,777▲ 24.8%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (3)
Financial year Type Filed Reference
31-12-2025 micro format 28-05-2026 2026-00128031
31-12-2024 micro format 12-08-2025 2025-00374478
31-12-2023 micro format 30-08-2024 2024-00427590

Similar companies · same sector, comparable size

Of the 9,156 active companies whose main activity is general medical practice (NACE 86210), figures are known for 6,437. 5,307 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
No directors read yet: 1 of 2 Gazette acts processed. See the directors and other office holders in the KBO →

Owners and capital

Owners

No owners or capital events in the accounts and acts we read.

History

On 16 May 2023, HALV was incorporated as a private limited company.1 In 2024 the registered office moved to Aalter.2 Total assets went from €40,308 in 2023 to €112,220 in 2025.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 11-03-2024
  3. 3National Bank, annual accounts 2023 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
28-05
NBB filing Annual accounts filed
financial year 2025 · micro format
2025
12-08
NBB filing Annual accounts filed
financial year 2024 · micro format · 12 days late
2024
31-12
Financial Highest result from 2023 to 2025net €43,884 ▲395%
Net result €43,884, the highest in the series.
31-12
Financial Liquidity more than triplescurrent ratio 4.19
Current ratio from 1.32 to 4.19; short-term debt falls from €29,437 to €16,894.
30-08
NBB filing Annual accounts filed
financial year 2023 · micro format · 30 days late
11-03
Gazette deed Registered office
Registered-office move2 facts ▸
  • General meeting, 26-12-2023
  • Registered-office move, Kestelstraat 105,9880 Aalter
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
1 of 2 deeds read
About the unread acts

Of the 2 Belgian Official Gazette deeds we know for this company, 1 has been read. The other one has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Register details

Identification
Legal formPrivate limited company
Founded16-05-2023
Financial year end31-12
Activities, NACEBEL 2025
86210General medical practice
E-invoicing
Reachable via Peppol
Peppol ID 0208:0801848223
Registered 07-05-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 25 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Recognitions · licences · registrations

Legal Entity Identifier

699400Z4ENASBIBVTP43
live in the LEI register

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Aalter · 1 establishment unit since 2023
registered office establishment The establishment unit on the map
Ground area
1,061 m²
Building footprint
128 m²
Parcel 44502C0505/00D000, Flanders. Linked by address, not a title deed.
3 companies at this address See who is registered here
1 establishment unit
HALV
Kestelstraat 105, 9880 AalterGeneral medical practice
since 2023unit no. 2.345.269.067
1 parcel
Flanders 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
44502C0505/00D000 Flanders 1,061 m² 1 · 127 m² -
How the parcels are linked
Good to know
The parcel matches the address exactly.